377 related articles for article (PubMed ID: 31629573)
1. Effect of Vitamin B
Li Y; Spence JD; Wang X; Huo Y; Xu X; Qin X
Am J Kidney Dis; 2020 Mar; 75(3):325-332. PubMed ID: 31629573
[TBL] [Abstract][Full Text] [Related]
2. Efficacy of Folic Acid Therapy on the Progression of Chronic Kidney Disease: The Renal Substudy of the China Stroke Primary Prevention Trial.
Xu X; Qin X; Li Y; Sun D; Wang J; Liang M; Wang B; Huo Y; Hou FF;
JAMA Intern Med; 2016 Oct; 176(10):1443-1450. PubMed ID: 27548766
[TBL] [Abstract][Full Text] [Related]
3. Effects of Folic Acid Therapy on the New-Onset Proteinuria in Chinese Hypertensive Patients: A Post Hoc Analysis of the Renal Substudy of CSPPT (China Stroke Primary Prevention Trial).
Li Y; Liang M; Wang G; Wang B; He M; Tang G; Yin D; Xu X; Huo Y; Cui Y; Hou FF; Qin X
Hypertension; 2017 Aug; 70(2):300-306. PubMed ID: 28607125
[TBL] [Abstract][Full Text] [Related]
4. Efficacy of folic acid therapy in primary prevention of stroke among adults with hypertension in China: the CSPPT randomized clinical trial.
Huo Y; Li J; Qin X; Huang Y; Wang X; Gottesman RF; Tang G; Wang B; Chen D; He M; Fu J; Cai Y; Shi X; Zhang Y; Cui Y; Sun N; Li X; Cheng X; Wang J; Yang X; Yang T; Xiao C; Zhao G; Dong Q; Zhu D; Wang X; Ge J; Zhao L; Hu D; Liu L; Hou FF;
JAMA; 2015 Apr; 313(13):1325-35. PubMed ID: 25771069
[TBL] [Abstract][Full Text] [Related]
5. Trends in Kidney Function Outcomes Following RAAS Inhibition in Patients With Heart Failure With Reduced Ejection Fraction.
McCallum W; Tighiouart H; Ku E; Salem D; Sarnak MJ
Am J Kidney Dis; 2020 Jan; 75(1):21-29. PubMed ID: 31303349
[TBL] [Abstract][Full Text] [Related]
6.
Huang X; Qin X; Yang W; Liu L; Jiang C; Zhang X; Jiang S; Bao H; Su H; Li P; He M; Song Y; Zhao M; Yin D; Wang Y; Zhang Y; Li J; Yang R; Wu Y; Hong K; Wu Q; Chen Y; Sun N; Li X; Tang G; Wang B; Cai Y; Hou FF; Huo Y; Wang H; Wang X; Cheng X
Arterioscler Thromb Vasc Biol; 2018 Mar; 38(3):679-685. PubMed ID: 29371246
[TBL] [Abstract][Full Text] [Related]
7. Effect of homocysteine lowering on mortality and vascular disease in advanced chronic kidney disease and end-stage renal disease: a randomized controlled trial.
Jamison RL; Hartigan P; Kaufman JS; Goldfarb DS; Warren SR; Guarino PD; Gaziano JM;
JAMA; 2007 Sep; 298(10):1163-70. PubMed ID: 17848650
[TBL] [Abstract][Full Text] [Related]
8. Controlled trials of very high dose folic acid, vitamins B12 and B6, intravenous folinic acid and serine for treatment of hyperhomocysteinemia in ESRD.
Gonin JM; Nguyen H; Gonin R; Sarna A; Michels A; Masri-Imad F; Bommareddy G; Chassaing C; Wainer I; Loya A; Cary D; Barker LF; Assefi A; Greenspan R; Mahoney D; Wilcox CS
J Nephrol; 2003; 16(4):522-34. PubMed ID: 14696754
[TBL] [Abstract][Full Text] [Related]
9. Folic acid with or without vitamin B12 for cognition and dementia.
Malouf M; Grimley EJ; Areosa SA
Cochrane Database Syst Rev; 2003; (4):CD004514. PubMed ID: 14584018
[TBL] [Abstract][Full Text] [Related]
10. Interaction of Serum Alkaline Phosphatase and Folic Acid Treatment on Chronic Kidney Disease Progression in Treated Hypertensive Adults.
Zhang Y; He P; Wang G; Liang M; Xie D; Nie J; Liu C; Song Y; Liu L; Wang B; Li J; Zhang Y; Wang X; Huo Y; Hou FF; Xu X; Qin X
Front Pharmacol; 2021; 12():753803. PubMed ID: 35095485
[TBL] [Abstract][Full Text] [Related]
11. Efficacy of Febuxostat for Slowing the GFR Decline in Patients With CKD and Asymptomatic Hyperuricemia: A 6-Month, Double-Blind, Randomized, Placebo-Controlled Trial.
Sircar D; Chatterjee S; Waikhom R; Golay V; Raychaudhury A; Chatterjee S; Pandey R
Am J Kidney Dis; 2015 Dec; 66(6):945-50. PubMed ID: 26233732
[TBL] [Abstract][Full Text] [Related]
12. [Should patients with chronic renal insufficiency be treated with folic acid, vitamin B6 and vitamin B12?].
Birn H
Ugeskr Laeger; 2008 Mar; 170(11):933-7. PubMed ID: 18397619
[TBL] [Abstract][Full Text] [Related]
13. Folic Acid Therapy Reduces the First Stroke Risk Associated With Hypercholesterolemia Among Hypertensive Patients.
Qin X; Li J; Spence JD; Zhang Y; Li Y; Wang X; Wang B; Sun N; Chen F; Guo J; Yin D; Sun L; Tang G; He M; Fu J; Cai Y; Shi X; Ye P; Chen H; Zhao S; Chen M; Gao C; Kong X; Hou FF; Huang Y; Huo Y
Stroke; 2016 Nov; 47(11):2805-2812. PubMed ID: 27729579
[TBL] [Abstract][Full Text] [Related]
14. Association of kidney disease outcomes with risk factors for CKD: findings from the Chronic Renal Insufficiency Cohort (CRIC) study.
Yang W; Xie D; Anderson AH; Joffe MM; Greene T; Teal V; Hsu CY; Fink JC; He J; Lash JP; Ojo A; Rahman M; Nessel L; Kusek JW; Feldman HI;
Am J Kidney Dis; 2014 Feb; 63(2):236-43. PubMed ID: 24182662
[TBL] [Abstract][Full Text] [Related]
15. Hyperhomocysteinemia predicts renal function decline: a prospective study in hypertensive adults.
Xie D; Yuan Y; Guo J; Yang S; Xu X; Wang Q; Li Y; Qin X; Tang G; Huo Y; Deng G; Wu S; Wang B; Zhang Q; Wang X; Fang P; Wang H; Xu X; Hou F
Sci Rep; 2015 Nov; 5():16268. PubMed ID: 26553372
[TBL] [Abstract][Full Text] [Related]
16. Folic acid therapy reduces serum uric acid in hypertensive patients: a substudy of the China Stroke Primary Prevention Trial (CSPPT).
Qin X; Li Y; He M; Tang G; Yin D; Liang M; Wang B; Nie J; Huo Y; Xu X; Hou FF
Am J Clin Nutr; 2017 Apr; 105(4):882-889. PubMed ID: 28148501
[No Abstract] [Full Text] [Related]
17. Folic acid with or without vitamin B12 for the prevention and treatment of healthy elderly and demented people.
Malouf R; Grimley Evans J
Cochrane Database Syst Rev; 2008 Oct; (4):CD004514. PubMed ID: 18843658
[TBL] [Abstract][Full Text] [Related]
18. Febuxostat Therapy for Patients With Stage 3 CKD and Asymptomatic Hyperuricemia: A Randomized Trial.
Kimura K; Hosoya T; Uchida S; Inaba M; Makino H; Maruyama S; Ito S; Yamamoto T; Tomino Y; Ohno I; Shibagaki Y; Iimuro S; Imai N; Kuwabara M; Hayakawa H; Ohtsu H; Ohashi Y;
Am J Kidney Dis; 2018 Dec; 72(6):798-810. PubMed ID: 30177485
[TBL] [Abstract][Full Text] [Related]
19. Folic acid therapy reduces the risk of mortality associated with heavy proteinuria among hypertensive patients.
Li Y; Qin X; Luo L; Wang B; Huo Y; Hou FF; Xu X
J Hypertens; 2017 Jun; 35(6):1302-1309. PubMed ID: 28441699
[TBL] [Abstract][Full Text] [Related]
20. Homocysteine and Stroke Risk: Modifying Effect of Methylenetetrahydrofolate Reductase C677T Polymorphism and Folic Acid Intervention.
Zhao M; Wang X; He M; Qin X; Tang G; Huo Y; Li J; Fu J; Huang X; Cheng X; Wang B; Hou FF; Sun N; Cai Y
Stroke; 2017 May; 48(5):1183-1190. PubMed ID: 28360116
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
